Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R O Dillman

Showing results (1-10 of 134) with videos related to

Pageof 14
Sort By:
Cancer Investigation|January 5, 2002
Monoclonal antibodies in the treatment of malignancy: basic concepts and recent developmentsR O Dillman
Critical Reviews in Oncology/Hematology|January 1, 1984
Monoclonal antibodies in the treatment of cancerR O Dillman
Biotechnology Therapeutics|January 1, 1989
Present status and future of monoclonal antibodiesR O Dillman
Clinical Lung Cancer|January 21, 2004
How can we improve survival rate for patients with non-small-cell lung cancer?R O Dillman
Seminars in Hematology|January 1, 1994
A new chemotherapeutic agent: deoxycoformycin (pentostatin)R O Dillman
The Cancer Journal From Scientific American|March 1, 1996
Concurrent chemoradiation in unresectable stage III non-small cell lung cancer: too much pain for no gainR O Dillman
Current Pharmaceutical Biotechnology|January 5, 2002
The history and rationale for monoclonal antibodies in the treatment of hematologic malignancyR O Dillman
Expert Opinion on Biological Therapy|December 1, 2001
15th Annual Scientific Meeting of the Society for Biological Therapy. 26-29 October 2000, Seattle, Washington, USAR O Dillman
The New England Journal of Medicine|February 16, 1984
Chromosomal translocation in a child with chronic lymphocytic leukemiaR O Dillman
Oncology (Williston Park, N.Y.)|March 1, 1992
Two letters cite errors in data in article on the Kern and DiSC assaysR O Dillman
Pageof 14

Showing results (1-10 of 134) with videos related to

Sort By:
Pageof 14
Cancer Investigation|January 5, 2002
Monoclonal antibodies in the treatment of malignancy: basic concepts and recent developmentsR O Dillman
Critical Reviews in Oncology/Hematology|January 1, 1984
Monoclonal antibodies in the treatment of cancerR O Dillman
Biotechnology Therapeutics|January 1, 1989
Present status and future of monoclonal antibodiesR O Dillman
Clinical Lung Cancer|January 21, 2004
How can we improve survival rate for patients with non-small-cell lung cancer?R O Dillman
Seminars in Hematology|January 1, 1994
A new chemotherapeutic agent: deoxycoformycin (pentostatin)R O Dillman
The Cancer Journal From Scientific American|March 1, 1996
Concurrent chemoradiation in unresectable stage III non-small cell lung cancer: too much pain for no gainR O Dillman
Current Pharmaceutical Biotechnology|January 5, 2002
The history and rationale for monoclonal antibodies in the treatment of hematologic malignancyR O Dillman
Expert Opinion on Biological Therapy|December 1, 2001
15th Annual Scientific Meeting of the Society for Biological Therapy. 26-29 October 2000, Seattle, Washington, USAR O Dillman
The New England Journal of Medicine|February 16, 1984
Chromosomal translocation in a child with chronic lymphocytic leukemiaR O Dillman
Oncology (Williston Park, N.Y.)|March 1, 1992
Two letters cite errors in data in article on the Kern and DiSC assaysR O Dillman
Pageof 14